Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Note 100 extends prescribability of antidiabetics to GPs and specialists
Similar content being viewed by others Subjects Introduction Adult obesity rates have more than doubled since 1990, while childhood and adolescent obesity have risen from 8% in 1990 to 20% in 2022, making this expanding health crisis an urgent priority given its profound impact on global morbidity and mortality 1,2
It can be really expensive to get services out of the primary network
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated greater efficacy in clinical trials, including the head-to-head SURMOUNT-5 trial comparing it to semaglutide 2.4 mg, potentially producing more substantial weight loss than traditional GLP-1 agonists alone
Yield: 2.4 gm
US$ 27.27
US$ 21.49
US$ 25.77
US$ 23.93
US$ 21.36
US$ 20.56
US$ 25.81
US$ 28.18
.png)
